NEWLY DIAGNOSED GLIOBLASTOMA
Clinical trials for NEWLY DIAGNOSED GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new NEWLY DIAGNOSED GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for NEWLY DIAGNOSED GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Brain tumor trial explores immune drug with radiation
Disease control OngoingThis early-phase trial tests whether adding the drug mycophenolate mofetil (MMF) to radiation therapy is safe for people with glioblastoma, an aggressive brain cancer. About 68 participants with newly diagnosed or recurrent glioblastoma will receive MMF alongside radiation. The m…
Matched conditions: NEWLY DIAGNOSED GLIOBLASTOMA
Phase: PHASE1 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New drug ST101 tested in patients with advanced cancers
Disease control OngoingThis study tests a new drug called ST101 in people with advanced solid tumors that cannot be removed by surgery or have spread. The goal is to find a safe dose and see if the drug can shrink tumors. About 125 adults with cancers like glioblastoma, melanoma, breast, or prostate ca…
Matched conditions: NEWLY DIAGNOSED GLIOBLASTOMA
Phase: PHASE1, PHASE2 • Sponsor: Sapience Therapeutics • Aim: Disease control
Last updated May 13, 2026 15:58 UTC